Table 3. Multivariate analysis of prognostic features that showed significant results in univariate analysis.
| Prognostic feature | P value | OR | 95% CI | |
|---|---|---|---|---|
| Gender [male/female] | 0.185 | 2.745 | 0.618 | 12.193 |
| ECOG 1 vs. 0 | 0.020 | 0.336 | 0.134 | 0.842 |
| ECOG 2 vs. 0 | 0.047 | 0.121 | 0.015 | 0.974 |
| ICIQ group mild vs. moderate | 0.394 | 1.76 | 0.48 | 6.449 |
| ICIQ group mild vs. severe | 0.382 | 0.504 | 0.109 | 2.342 |
| Surgeon experience <100 vs. >100 prev. rCx [y/n] | 0.021 | 3.442 | 1.203 | 9.847 |
| Nerve-sparing [y/n] | 0.165 | 2.029 | 0.747 | 5.511 |
| Radiation therapy [y/n] | 0.999 | 0 | 0 | . |
| Symptoms [y/n] | 0.109 | 0.458 | 0.176 | 1.192 |
| Urge [y/n] | 0.259 | 0.486 | 0.139 | 1.702 |
| Daytime continence [y/n] | 0.032 | 3.131 | 1.101 | 8.908 |
| Daily pad usage 2 vs. 0-1 | 0.817 | 0.859 | 0.238 | 3.105 |
| Daily pad usage >2 vs. 0-1 | 0.995 | 0.996 | 0.274 | 3.616 |
CI = confidence interval; ECOG = Eastern Cooperative Oncology Group performance status score; ICIQ = International Consultation on Incontinence Questionnaire; OR = odds ratio; RCX = radical cystectomy.
A p value >0.05 was considered statistically signifcant.